Guangdong Kanghua Healthcare Co., Ltd. Class H ( (HK:3689) ) just unveiled an update.
Guangdong Kanghua Healthcare Group Co., Ltd. has issued a profit warning for the fiscal year 2024, anticipating a significant drop in profits compared to the previous year. The decline is attributed to national policy reforms, reduced demand post-COVID-19, and increased operational costs. Additionally, the acquisition of a loss-making haemodialysis business and continued losses from its cardiovascular hospital have further impacted the company’s financial performance. The company also expects a fair value loss from an investment fund, contributing to the overall financial pressure.
More about Guangdong Kanghua Healthcare Co., Ltd. Class H
Guangdong Kanghua Healthcare Group Co., Ltd. is a healthcare company based in the People’s Republic of China, primarily involved in the operation of hospitals and healthcare facilities. The company focuses on providing medical services and has recently expanded into haemodialysis outpatient centers.
YTD Price Performance: -16.39%
Average Trading Volume: 16,640
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$682.2M
Learn more about 3689 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com